ZA200900905B - Modified-galactosyl ceramides for staining and stimulating Natural Killer T cells - Google Patents

Modified-galactosyl ceramides for staining and stimulating Natural Killer T cells

Info

Publication number
ZA200900905B
ZA200900905B ZA200900905A ZA200900905A ZA200900905B ZA 200900905 B ZA200900905 B ZA 200900905B ZA 200900905 A ZA200900905 A ZA 200900905A ZA 200900905 A ZA200900905 A ZA 200900905A ZA 200900905 B ZA200900905 B ZA 200900905B
Authority
ZA
South Africa
Prior art keywords
staining
cells
modified
natural killer
stimulating natural
Prior art date
Application number
ZA200900905A
Other languages
English (en)
Inventor
Paul B Savage
Luc Teyton
Albert Bendelac
Original Assignee
Scripps Research Inst
Univ Brigham Young
Univ Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst, Univ Brigham Young, Univ Chicago filed Critical Scripps Research Inst
Publication of ZA200900905B publication Critical patent/ZA200900905B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA200900905A 2006-04-07 2009-02-06 Modified-galactosyl ceramides for staining and stimulating Natural Killer T cells ZA200900905B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79009606P 2006-04-07 2006-04-07

Publications (1)

Publication Number Publication Date
ZA200900905B true ZA200900905B (en) 2010-06-30

Family

ID=38581864

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900905A ZA200900905B (en) 2006-04-07 2009-02-06 Modified-galactosyl ceramides for staining and stimulating Natural Killer T cells

Country Status (12)

Country Link
US (2) US8227581B2 (de)
EP (1) EP2056842B1 (de)
AU (1) AU2007234753B2 (de)
BR (1) BRPI0710668A2 (de)
CA (1) CA2661789C (de)
DK (1) DK2056842T3 (de)
ES (1) ES2397975T3 (de)
PL (1) PL2056842T3 (de)
PT (1) PT2056842E (de)
SI (1) SI2056842T1 (de)
WO (1) WO2007118234A2 (de)
ZA (1) ZA200900905B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645873B2 (en) 2003-03-20 2010-01-12 The Scripps Research Institute 6″-amino-6″-deoxygalactosylceramides
PT1848813E (pt) 2005-01-28 2013-07-15 Scripps Research Inst Activação de glicolípidos bacterianos de células nkt restritas ao cd1d
EP2040541B1 (de) 2006-06-30 2016-03-23 The Scripps Research Institute Hilfsstoffe und verwendungsverfahren
US8916164B2 (en) * 2007-08-29 2014-12-23 Abivax Methods of enhancing adjuvaticity of vaccine compositions
AU2013202865B2 (en) * 2007-11-07 2015-03-19 Abivax Increase of immune response and targeting by antigens and/or drug linkage
EP2058011A1 (de) * 2007-11-07 2009-05-13 Wittycell NKT-Zellen aktivierende, kovalent gebundene Glykolipid-Antigene und/oder Arzneimittel
RU2537188C2 (ru) 2007-12-05 2014-12-27 Виттисель Композиции и способы для усиления имунного ответа на антигены
JP5809560B2 (ja) 2008-10-08 2015-11-11 アビヴァックス インフルエンザに対して使用するためのワクチン組成物
ES2345377B1 (es) * 2009-03-20 2011-07-21 Consejo Superior De Investigaciones Cientificas (Csis) (51%) Compuestos aminociclitoles, procedimiento de obtencion y usos.
WO2011112889A2 (en) 2010-03-12 2011-09-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services β-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY
EP2842961B1 (de) 2012-04-26 2016-12-14 Riken Neues carbamat-glykolipid und verwendung davon
US9321796B2 (en) 2012-06-28 2016-04-26 Universiteit Gent Galactopyranosyl derivatives useful as medicaments
EP2727929A1 (de) * 2012-10-30 2014-05-07 Wittycell Verfahren zur Herstellung von Alpha-Galactosyl-Ceramid-Verbindungen
US20170029454A1 (en) * 2013-06-28 2017-02-02 The Scripps Research Institute Nkt cell ligands and methods of use
WO2015187040A1 (en) * 2014-06-05 2015-12-10 Regan James Anderson Amino sphingoglycolipid analogues
ES2999021T3 (en) 2016-09-14 2025-02-24 Abivax Combinations including abx196 for the treatment of cancer
WO2019190986A1 (en) * 2018-03-26 2019-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 3-o-sulfo-galactosylceramide analogs as activators of type ii nkt cells and uses thereof
WO2023121483A1 (en) * 2021-12-24 2023-06-29 Victoria Link Limited Immunostimulatory compositions
CN115286667B (zh) * 2022-08-02 2024-03-26 华中农业大学 一种α-半乳糖基神经酰胺类似物及其制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242800A (en) 1990-01-30 1993-09-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Receptor for pathogenic fungi
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (de) 1992-07-16 1995-11-01 Kirin Brewery
AU683026B2 (en) 1992-10-22 1997-10-30 Kirin Pharma Kabushiki Kaisha Novel shingoglycolipid and use thereof
EP0694558B1 (de) 1993-04-15 1999-01-27 Kirin Beer Kabushiki Kaisha Sphingoglycolipid und verwendung davon
CZ298895A3 (en) 1993-05-14 1996-04-17 Cytel Corp Compound analogous to sialyl lex, pharmaceutical composition containing thereof and process for preparing lactosammonium salt
US6054433A (en) 1994-11-03 2000-04-25 The Regents Of The University Of California Methods and compositions for stimulating tissue growth and epithelial moisturization
US5785975A (en) 1995-06-26 1998-07-28 Research Triangle Pharmaceuticals Adjuvant compositions and vaccine formulations comprising same
EP0821068A3 (de) 1996-03-29 1999-06-02 Rohm And Haas Company Sphingolipide and Verfahren dazu
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
CA2280130C (en) 1997-02-05 2007-12-18 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
JP3495740B2 (ja) 1997-04-10 2004-02-09 麒麟麦酒株式会社 α−グリコシルセラミドを含有するＮＫＴ細胞活性化剤
US6492337B1 (en) 1997-12-30 2002-12-10 A+ Science Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complication
DE69943314D1 (de) 1998-02-12 2011-05-12 Kapil N Bhalla Sphingolipid-derivate und verfahren zu deren verwendung
US20030157113A1 (en) * 1999-12-28 2003-08-21 Terman David S. Compositions and methods for treatment of neoplastic disease
AU2001252599A1 (en) 2000-04-28 2001-11-12 Orient Cancer Therapy Co., Ltd. Remedies for cancer
JP4410913B2 (ja) 2000-06-12 2010-02-10 壽製薬株式会社 新規糖脂質誘導体の製造方法
WO2001098317A2 (en) 2000-06-22 2001-12-27 The Brigham And Women's Hospital, Inc. Alpha-glycosylceramides for treating bacterial and fungal infections
AR034413A1 (es) 2000-08-25 2004-02-25 Nestor Abel Chamoles Metodo para determinar la actividad de las enzimas lisosomales
EP1434859A2 (de) 2001-07-25 2004-07-07 New York University Verwendung von glycosylceramiden als adjuvantien für vakzine gegen infektionen und krebs
KR100549866B1 (ko) 2001-08-22 2006-02-08 고려대학교 산학협력단 암치료 및 예방 제제
KR20050043736A (ko) 2001-11-06 2005-05-11 오리엔트 캔서 세라피 컴퍼니 리미티드 항암 조성물
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
AU2003251518B2 (en) 2002-06-13 2009-07-02 New York University Synthetic C-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
US7645873B2 (en) * 2003-03-20 2010-01-12 The Scripps Research Institute 6″-amino-6″-deoxygalactosylceramides
AU2003225891A1 (en) * 2003-03-20 2004-11-19 Brigham Young University 6"-amino-6"-deoxygalactosylceramides
GB0314682D0 (en) 2003-06-24 2003-07-30 Isis Innovation Materials and methods relating to the modulation of T cell response to soluble antigen
US7771726B2 (en) 2003-10-08 2010-08-10 New York University Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
CA2560969A1 (en) 2004-03-31 2005-11-03 New York University Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
EP1784196B1 (de) 2004-08-27 2016-12-21 Albert Einstein College Of Medicine Of Yeshiva University Ceramid-derivate als modulatoren von immunität und autoimmunität
CA2578052C (en) 2004-09-03 2013-08-13 The University Of Chicago Methods of activating nkt cells
US7534434B2 (en) 2004-12-28 2009-05-19 The Rockefeller University Glycolipids and analogues thereof as antigens for NK T cells
PT1848813E (pt) 2005-01-28 2013-07-15 Scripps Research Inst Activação de glicolípidos bacterianos de células nkt restritas ao cd1d
KR100764678B1 (ko) 2005-07-13 2007-10-09 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드를 아쥬반트로 포함하는 비강투여용 백신 조성물
BRPI0617687A2 (pt) 2005-10-25 2011-08-02 Ludwig Inst Cancer Res composto, método para proteger um indivìduo mamìfero contra, ou tratar, um vìrus, infecção microbiana, parasita, uma doença auto-imune, cáncer, alergia ou asma, e, composição farmacêutica
EP2040541B1 (de) 2006-06-30 2016-03-23 The Scripps Research Institute Hilfsstoffe und verwendungsverfahren
EP1938836A1 (de) 2006-12-28 2008-07-02 Universite Rene Descartes (Paris V) Verbindungen mit Shigatoxin-B-Untereinheit und Mittel zur Stimulation von NKT-Zellen

Also Published As

Publication number Publication date
CA2661789A1 (en) 2007-10-18
AU2007234753B2 (en) 2013-02-21
PT2056842E (pt) 2013-01-24
US20090047299A1 (en) 2009-02-19
CA2661789C (en) 2014-06-03
WO2007118234A2 (en) 2007-10-18
SI2056842T1 (sl) 2013-02-28
US20120270815A1 (en) 2012-10-25
PL2056842T3 (pl) 2013-03-29
WO2007118234A3 (en) 2007-12-06
EP2056842A4 (de) 2010-10-06
EP2056842B1 (de) 2012-10-17
DK2056842T3 (da) 2013-01-14
ES2397975T3 (es) 2013-03-12
BRPI0710668A2 (pt) 2011-08-16
AU2007234753A1 (en) 2007-10-18
US8765692B2 (en) 2014-07-01
US8227581B2 (en) 2012-07-24
EP2056842A2 (de) 2009-05-13

Similar Documents

Publication Publication Date Title
ZA200900905B (en) Modified-galactosyl ceramides for staining and stimulating Natural Killer T cells
IL202329A0 (en) Methods and compositions for stimulating cells
PT2066399T (pt) Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
EP2089507A4 (de) Hocheffiziente vorrichtungen und verfahren zur zellkultivierung
AP3322A (en) Cell assay kit and method
IL221384A0 (en) Improving il-15 and il-15r-alpha for expression in mammalian cells
GB2479680B (en) Refuge chamber and method
ZA200810290B (en) Grain refiners for steel-manufacturing methods and use
EP2095098A4 (de) Probenträgerstruktur und verfahren
SG10201510384UA (en) Cell culture improvements
IL197781A0 (en) Lyophilization methods and apparatuses
IL204682A0 (en) Artificial marble and methods
IL211089A0 (en) Compositions and methods for cell killing
PL2102354T3 (pl) Urządzenie i sposoby osmotycznego szokowania komórek
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
GB0605702D0 (en) Materials and methods for immune cell stimulation
EP2227540A4 (de) Entdifferenzierung menschlicher zellen
GB0700302D0 (en) Method and kit
ZA200907150B (en) New compositions and methods for cell killing
EP2115127A4 (de) Verfahren und zusammensetzungen zur verbesserung der zellgesundheit in kulturen
GB0606671D0 (en) Cell Culture
GB0701037D0 (en) Grooming aid and related methods
EP2185685A4 (de) Neue verfahren und zelllinien
GB0715201D0 (en) Flavonoids-rich tissues from neomarica gracilis and methods for culturing the same
GB0617564D0 (en) Peptides and methods